Financing, Equity Capital Markets

ChemoCentryx, Inc.

06/20
|
$346.8 Million
Piper Sandler served as bookrunner for ChemoCentryx, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma